샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774927

세계의 수신증 치료 시장

Hydronephrosis Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 561 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 수신증 치료 시장은 2030년까지 38억 달러에 이를 전망

2024년에 25억 달러로 추정되는 수신증 치료 세계 시장은 분석 기간인 2024-2030년 CAGR 7.1%로 성장하여 2030년에는 38억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 일측성 수신증 유형은 CAGR 8.5%를 나타내고, 분석 기간 종료까지 25억 달러에 이를 것으로 예측됩니다. 양측성 수신증 유형 부문의 성장률은 분석 기간에 CAGR 4.9%로 추정됩니다.

미국 시장은 6억 8,640만 달러로 추정, 중국은 CAGR 11.4%로 성장 예측

미국의 수신증 치료 시장은 2024년에 6억 8,640만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2024-2030년의 분석 기간에 CAGR 11.4%로 성장을 지속하여, 2030년에는 8억 1,070만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.4%와 7.0%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.7%로 성장할 전망입니다.

세계의 수신증 치료 시장 - 주요 동향과 촉진요인 정리

전 세계적으로 수족구병 치료 수요가 증가하는 이유

신장 결석, 요로 감염(UTI), 선천성 요로 이상, 노화에 따른 비뇨기 질환 증가로 인해 소변이 쌓여 한쪽 또는 양쪽 신장이 부어 오르는 수액신증은 다양한 계층에서 점점 더 흔해지고 있습니다. 특히 고령화 사회와 당뇨병 및 고혈압과 같은 만성 건강 상태를 가진 사람들 사이에서 이러한 근본적인 원인의 전 세계 유병률이 증가함에 따라 효과적인 수족구병 진단 및 치료의 필요성이 크게 증가하고 있습니다. 또한, 신생아 선별 검사 프로그램을 통해 선천성 수족구병이 발견되는 빈도가 높아지면서 조기 개입 및 소아 치료 옵션에 대한 수요가 증가하고 있습니다. 요로폐색으로 인한 통증, 감염, 신장 기능 저하를 경험한 환자들은 약물 치료와 카테터 치료부터 수술적 교정까지 적시에 개입해야 합니다. 신장 건강에 대한 인식 증가, 영상 기술의 발전, 1차 진료에 비뇨기과 서비스의 통합은 모두 조기 진단 및 조기 치료로 이어져 세계 수족구병 치료 시장의 성장을 가속하고 있습니다.

기술 혁신과 수술 혁신이 수족구병 관리를 어떻게 개선하고 있는가?

기술의 발전은 보다 정확하고, 덜 침습적이며, 환자 중심의 솔루션을 제공함으로써 수신증 치료의 상황을 재구성하고 있습니다. 고해상도 초음파 검사, CT 요로조영술, 자기공명 요로조영술(MRU) 등의 영상 기술은 요로폐색의 조기 발견과 정확한 평가에 중요한 역할을 하고 있습니다. 치료 측면에서는 내시경 및 복강경 수술이 회복 시간 단축, 수술 후 통증 감소, 합병증 감소 등 최소 침습적 시술이 가능해져 환자의 예후를 획기적으로 개선하고 있습니다. 예를 들어, 경피적 신루술, 요관 스텐트 삽입술, 신우신우성형술(개복 또는 로봇 보조)은 중증 환자의 표준 치료법으로 자리 잡았습니다. 특히 로봇 수술은 더 높은 정확도와 합병증 감소를 실현함으로써 특히 소아 및 재수술 상황에서 복잡한 재건술에 혁명을 일으켰습니다. 또한, 감염 제어를 위한 표적 항생제, 특정 케이스에서 소변의 흐름을 돕는 알파차단제 등 약물요법의 혁신이 수술 이외의 치료 효과를 높이고 있습니다. 이러한 의료 및 수술의 발전으로 수족구병 치료는 더 안전하고, 더 빠르고, 더 맞춤화되어 시장의 폭을 넓혀가고 있습니다.

헬스케어 정책과 진단약 접근성이 시장 성장에 어떤 역할을 할 것인가?

의료 접근성과 공중보건 정책은 수족구병의 진단과 치료에 직접적인 영향을 미치며, 특히 진단이 늦어질수록 병이 더 진행되기 쉬운 신흥국에서는 그 영향이 큽니다. 정부와 보건 기관은 신생아, 임산부(태아 수족구병 검출), 비뇨기 질환 병력이 있는 노인 등 위험군에 대한 정기적인 검진을 점점 더 많이 추진하고 있습니다. 농촌 지역이나 의료 서비스가 부족한 지역에서 영상 진단을 이용할 수 있게 되는 등 의료 인프라의 개선도 조기 발견과 조기 관리에 기여하고 있습니다. 첨단 영상 진단 및 수술적 개입에 대한 보험 적용 및 상환 정책은 공공 및 민간 의료 시스템 모두에서 치료의 실행에 영향을 미치는 중요한 요소입니다. 또한, 국가 비뇨기과 가이드라인과 치료되지 않은 수족구병의 징후와 결과에 대한 인식이 높아짐에 따라 환자들이 더 일찍 진료를 받도록 유도하고 있습니다. 진단 능력이 확대되고 의료 시스템이 적시에 비뇨기과 의료 서비스를 제공할 수 있는 능력이 향상됨에 따라 더 많은 환자들이 질병의 초기 단계에서 중재를 받게 되어 시장 성장을 더욱 촉진하고 있습니다.

수족구병 치료제 시장의 성장 촉진요인은?

수족구병 치료 시장의 성장은 인구 고령화, 원인 비뇨기 질환의 유병률 증가, 진단 및 수술의 발전, 전문 의료 서비스에 대한 접근성 확대 등 여러 가지 상호 연관된 요인으로 인해 발생합니다. 첫째, 전 세계적으로 요로폐색, 전립선 비대증, 신장 기능 장애에 취약한 노인 인구 증가로 인해 수뇨증 발생률이 크게 증가하여 비뇨기과 치료에 대한 수요가 증가하고 있습니다. 둘째, 비만, 당뇨, 고혈압 등 생활습관병의 부담 증가가 신장의 부종으로 이어지는 이차적 합병증의 원인이 되고 있습니다. 셋째, 최소침습적 수술 기법과 의료용 영상진단의 끊임없는 기술 혁신으로 수액신증 치료를 보다 효과적이고 쉽게 이용할 수 있게 되었습니다. 넷째, 비뇨기과 검진을 1차 진료에 포함시키는 공중보건 노력은 환자 교육 개선과 함께 조기 진단 및 조기 개입으로 이어지고 있습니다. 마지막으로, 의료 인프라에 대한 투자와 보험의 보급에 힘입어 신흥국에서의 고급 의료 서비스 제공 시스템의 출현으로 수족구병 치료의 환자 기반이 확대되고 있습니다. 이러한 추세와 함께 수족구병 치료 시장은 모든 연령대에서 보다 빠르고 안전하며, 보다 타겟팅된 치료 전략으로 인해 강력한 성장세를 보이고 있습니다.

부문

유형(일측성 수신증 유형, 양측성 수신증 유형);적응증(내인성 적응증, 외인성 적응증);진단(임상 검사 진단, 영상 진단);치료(충격파 결석 파쇄 치료, 복강경 치료, 방광 카테터 치료, 스테로이드 요법 치료, 기타 치료 유형);연령층(성인, 소아)

조사 대상 기업 예

  • 3M Company
  • AbbVie Inc.
  • Allergan
  • Amgen Inc.
  • Anthem Bio Pharm
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Coloplast A/S
  • Cook Medical
  • F. Hoffmann-La Roche Ltd
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • NephroGenex, Inc.
  • Novartis AG
  • Olympus Corporation
  • PHRAXIS, INC.
  • Sanofi
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.31

Global Hydronephrosis Treatment Market to Reach US$3.8 Billion by 2030

The global market for Hydronephrosis Treatment estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Unilateral Hydronephrosis Type, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Bilateral Hydronephrosis Type segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$686.4 Million While China is Forecast to Grow at 11.4% CAGR

The Hydronephrosis Treatment market in the U.S. is estimated at US$686.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$810.7 Million by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Hydronephrosis Treatment Market - Key Trends & Drivers Summarized

Why Is the Demand for Hydronephrosis Treatment Increasing Worldwide?

Hydronephrosis, the swelling of one or both kidneys due to urine buildup, is becoming increasingly common across various demographics due to rising incidences of kidney stones, urinary tract infections (UTIs), congenital urinary tract abnormalities, and age-related urological issues. The growing global prevalence of these underlying causes, especially among aging populations and individuals with chronic health conditions like diabetes and hypertension, is significantly increasing the need for effective hydronephrosis diagnosis and treatment. Neonatal screening programs are also detecting congenital hydronephrosis more frequently, contributing to early intervention and the demand for pediatric treatment options. Patients experiencing pain, infection, or compromised kidney function due to obstruction of the urinary flow require timely intervention-ranging from medication and catheterization to surgical correction. The rise in awareness about kidney health, advancements in imaging technologies, and the integration of urological services into primary care are all leading to earlier diagnosis and treatment, fueling growth in the global hydronephrosis treatment market.

How Are Technological and Surgical Innovations Improving Hydronephrosis Management?

Technological advancements are reshaping the landscape of hydronephrosis treatment, offering more precise, minimally invasive, and patient-centric solutions. Imaging technologies such as high-resolution ultrasonography, CT urography, and magnetic resonance urography (MRU) are playing a critical role in early detection and accurate assessment of urinary tract obstructions. On the therapeutic side, endoscopic and laparoscopic surgical techniques have dramatically improved patient outcomes by enabling less invasive procedures with quicker recovery times, reduced postoperative pain, and lower complication rates. For instance, percutaneous nephrostomy, ureteral stenting, and pyeloplasty-either open or robotic-assisted-have become standard interventions for managing severe cases. Robotic surgery, in particular, has revolutionized complex reconstructive procedures, especially in pediatric and repeat-surgery scenarios, by offering higher precision and fewer complications. Furthermore, innovations in drug therapy, such as targeted antibiotics for infection control and alpha-blockers to aid urine flow in certain cases, are enhancing non-surgical treatment effectiveness. These medical and surgical advances are making hydronephrosis treatment safer, faster, and more personalized, broadening the market scope.

What Role Do Healthcare Policies and Diagnostics Access Play in Market Growth?

Healthcare access and public health policies have a direct impact on the diagnosis and treatment of hydronephrosis, especially in emerging economies where late diagnosis often results in more advanced disease states. Governments and health organizations are increasingly promoting routine screening for at-risk populations, including newborns, pregnant women (to detect fetal hydronephrosis), and older adults with a history of urological disorders. Improvements in healthcare infrastructure-such as the availability of diagnostic imaging in rural and underserved areas-are also contributing to earlier detection and management. Insurance coverage and reimbursement policies for advanced imaging and surgical interventions are critical factors influencing treatment uptake in both public and private healthcare systems. Additionally, national urology guidelines and increased awareness campaigns about the signs and consequences of untreated hydronephrosis are driving patients to seek earlier medical consultation. As diagnostic capabilities expand and healthcare systems improve their ability to provide timely urologic care, more patients are receiving interventions at earlier stages of the disease, further propelling market growth.

What Are the Key Drivers of Growth in the Hydronephrosis Treatment Market?

The growth in the hydronephrosis treatment market is driven by multiple interconnected factors, including an aging population, increasing prevalence of causative urological conditions, advancements in diagnostics and surgery, and expanding access to specialized healthcare. First, the global increase in elderly populations-who are more prone to urinary tract obstructions, enlarged prostates, and kidney dysfunction-has significantly raised the incidence of hydronephrosis and the demand for urological care. Second, the rising burden of lifestyle-related diseases such as obesity, diabetes, and hypertension is contributing to secondary complications that lead to kidney swelling. Third, continual innovation in minimally invasive surgical techniques and medical imaging is making hydronephrosis treatment more effective and accessible. Fourth, public health efforts to integrate urological screening into primary care, along with better patient education, are leading to earlier diagnosis and intervention. Lastly, the emergence of advanced healthcare delivery systems in developing countries-supported by investments in medical infrastructure and insurance penetration-is expanding the patient base for hydronephrosis care. Together, these trends are driving robust growth in the hydronephrosis treatment market, with a focus on faster, safer, and more targeted care strategies across all age groups.

SCOPE OF STUDY:

The report analyzes the Hydronephrosis Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Unilateral Hydronephrosis Type, Bilateral Hydronephrosis Type); Indication (Intrinsic Indication, Extrinsic Indication); Diagnosis (Laboratory Tests Diagnosis, Imaging Diagnosis); Treatment (Shock Wave Lithotripsy Treatment, Laparoscopy Treatment, Bladder Catheterization Treatment, Steroid Therapy Treatment, Other treatment types); Age Group (Adult, Pediatric)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 3M Company
  • AbbVie Inc.
  • Allergan
  • Amgen Inc.
  • Anthem Bio Pharm
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Coloplast A/S
  • Cook Medical
  • F. Hoffmann-La Roche Ltd
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • NephroGenex, Inc.
  • Novartis AG
  • Olympus Corporation
  • PHRAXIS, INC.
  • Sanofi
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Hydronephrosis Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Kidney Disorders Throws the Spotlight on Hydronephrosis Treatment Options
    • Increasing Geriatric Population Spurs Demand for Non-Invasive and Minimally Invasive Therapies
    • Advancements in Diagnostic Imaging Strengthen the Business Case for Early Detection and Intervention
    • Here's How Technological Innovation in Ureteral Stents and Catheters Drives Treatment Optimization
    • Growth in Pediatric Urology Expands the Addressable Market for Congenital Hydronephrosis Management
    • Surge in Outpatient and Ambulatory Surgical Centers Accelerates Access to Hydronephrosis Procedures
    • Here's the Story: Patient Preference for Faster Recovery Fuels Adoption of Minimally Invasive Procedures
    • Integration of AI in Diagnostic Pathways Strengthens Decision-Making and Risk Stratification
    • Challenges in Rural Healthcare Access Create Opportunities for Telemedicine-Enabled Urological Consultations
    • Emerging Markets Invest in Urology Infrastructure, Unlocking Growth Opportunities for Treatment Providers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hydronephrosis Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hydronephrosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hydronephrosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Unilateral Hydronephrosis Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Unilateral Hydronephrosis Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Unilateral Hydronephrosis Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bilateral Hydronephrosis Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Bilateral Hydronephrosis Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Bilateral Hydronephrosis Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Steroid Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Steroid Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Steroid Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other treatment types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other treatment types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other treatment types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Shock Wave Lithotripsy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Shock Wave Lithotripsy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Shock Wave Lithotripsy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Laparoscopy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Laparoscopy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Laparoscopy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Bladder Catheterization Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Bladder Catheterization Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Bladder Catheterization Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Intrinsic Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Intrinsic Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Intrinsic Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Extrinsic Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Extrinsic Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Extrinsic Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Laboratory Tests Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Laboratory Tests Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Laboratory Tests Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Imaging Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Imaging Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Imaging Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • JAPAN
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Japan 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • CHINA
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 89: China Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: China 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: China 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • EUROPE
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Hydronephrosis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Hydronephrosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Europe 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Europe 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Europe 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • FRANCE
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 122: France Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: France 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: France 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: France 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 131: France Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: France 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: France 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • GERMANY
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Germany 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Germany 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Germany 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Germany 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Germany 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Italy 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Italy 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Italy 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Italy 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Italy 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 167: UK Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: UK Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: UK 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 170: UK Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: UK 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: UK 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 176: UK Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: UK 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 179: UK Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: UK 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 182: Spain Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Spain Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Spain 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 185: Spain Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Spain Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Spain 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 188: Spain Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Spain Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Spain 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 191: Spain Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Spain Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Spain 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 194: Spain Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Spain Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Spain 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 197: Russia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Russia Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Russia 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 200: Russia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Russia Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Russia 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 203: Russia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Russia Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Russia 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 206: Russia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Russia Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Russia 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 209: Russia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Russia Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Russia 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Europe Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Europe 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 215: Rest of Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Europe Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Europe 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Europe Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Europe 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 221: Rest of Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Europe Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Europe 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Europe Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Europe 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 228: Asia-Pacific Historic Review for Hydronephrosis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 230: Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Asia-Pacific Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 233: Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Asia-Pacific Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 236: Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Asia-Pacific Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Asia-Pacific Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Asia-Pacific Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 245: Australia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Australia Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Australia 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 248: Australia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Australia Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Australia 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 251: Australia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Australia Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Australia 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 254: Australia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Australia Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Australia 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 257: Australia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Australia Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Australia 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • INDIA
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 260: India Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: India Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: India 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 263: India Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: India Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: India 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 266: India Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: India Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: India 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 269: India Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: India Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: India 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 272: India Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: India Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: India 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 275: South Korea Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: South Korea Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: South Korea 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 278: South Korea Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: South Korea Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: South Korea 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 281: South Korea Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: South Korea Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: South Korea 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 284: South Korea Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: South Korea Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: South Korea 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 287: South Korea Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: South Korea Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: South Korea 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 290: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Asia-Pacific Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Asia-Pacific Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Asia-Pacific Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Asia-Pacific Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Asia-Pacific Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Asia-Pacific 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 305: Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 306: Latin America Historic Review for Hydronephrosis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Latin America 15-Year Perspective for Hydronephrosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 308: Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Latin America Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Latin America 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 311: Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Latin America Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Latin America 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 314: Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Latin America Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Latin America 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 317: Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Latin America Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Latin America 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 320: Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Latin America Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Latin America 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 323: Argentina Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Argentina Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Argentina 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 326: Argentina Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Argentina Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Argentina 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 329: Argentina Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Argentina Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Argentina 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 332: Argentina Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Argentina Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Argentina 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 335: Argentina Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Argentina Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Argentina 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 338: Brazil Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Brazil Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Brazil 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 341: Brazil Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Brazil Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Brazil 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 344: Brazil Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Brazil Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Brazil 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 347: Brazil Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Brazil Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Brazil 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 350: Brazil Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Brazil Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Brazil 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 353: Mexico Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Mexico Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Mexico 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 356: Mexico Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Mexico Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Mexico 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 359: Mexico Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Mexico Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Mexico 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 362: Mexico Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Mexico Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Mexico 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 365: Mexico Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Mexico Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Mexico 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 368: Rest of Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Rest of Latin America Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Rest of Latin America 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 371: Rest of Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Latin America Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Latin America 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Latin America Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Latin America 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Latin America Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Latin America 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Latin America Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Latin America Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Latin America 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 383: Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 384: Middle East Historic Review for Hydronephrosis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Middle East 15-Year Perspective for Hydronephrosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 386: Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Middle East Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Middle East 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 389: Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Middle East Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Middle East 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 392: Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Middle East Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Middle East 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 395: Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Middle East Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Middle East 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 398: Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Middle East Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Middle East 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 401: Iran Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Iran Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Iran 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 404: Iran Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Iran Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: Iran 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 407: Iran Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Iran Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Iran 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 410: Iran Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Iran Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 412: Iran 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 413: Iran Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Iran Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 415: Iran 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 416: Israel Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Israel Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 418: Israel 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 419: Israel Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Israel Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 421: Israel 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 422: Israel Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Israel Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 424: Israel 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 425: Israel Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Israel Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 427: Israel 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 428: Israel Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 429: Israel Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 430: Israel 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 431: Saudi Arabia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 432: Saudi Arabia Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 433: Saudi Arabia 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 434: Saudi Arabia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 435: Saudi Arabia Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 436: Saudi Arabia 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 437: Saudi Arabia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 438: Saudi Arabia Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 439: Saudi Arabia 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 440: Saudi Arabia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 441: Saudi Arabia Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 442: Saudi Arabia 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 443: Saudi Arabia Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 444: Saudi Arabia Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 445: Saudi Arabia 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 446: UAE Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 447: UAE Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 448: UAE 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 449: UAE Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 450: UAE Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 451: UAE 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 452: UAE Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 453: UAE Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 454: UAE 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 455: UAE Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 456: UAE Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 457: UAE 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 458: UAE Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 459: UAE Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 460: UAE 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 461: Rest of Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 462: Rest of Middle East Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 463: Rest of Middle East 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 464: Rest of Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 465: Rest of Middle East Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 466: Rest of Middle East 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 467: Rest of Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 468: Rest of Middle East Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 469: Rest of Middle East 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 470: Rest of Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 471: Rest of Middle East Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 472: Rest of Middle East 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 473: Rest of Middle East Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 474: Rest of Middle East Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 475: Rest of Middle East 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030
  • AFRICA
    • Hydronephrosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 476: Africa Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 477: Africa Historic Review for Hydronephrosis Treatment by Type - Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 478: Africa 15-Year Perspective for Hydronephrosis Treatment by Type - Percentage Breakdown of Value Sales for Unilateral Hydronephrosis Type and Bilateral Hydronephrosis Type for the Years 2015, 2025 & 2030
    • TABLE 479: Africa Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 480: Africa Historic Review for Hydronephrosis Treatment by Treatment - Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 481: Africa 15-Year Perspective for Hydronephrosis Treatment by Treatment - Percentage Breakdown of Value Sales for Steroid Therapy Treatment, Other treatment types, Shock Wave Lithotripsy Treatment, Laparoscopy Treatment and Bladder Catheterization Treatment for the Years 2015, 2025 & 2030
    • TABLE 482: Africa Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Age Group - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 483: Africa Historic Review for Hydronephrosis Treatment by Age Group - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 484: Africa 15-Year Perspective for Hydronephrosis Treatment by Age Group - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
    • TABLE 485: Africa Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 486: Africa Historic Review for Hydronephrosis Treatment by Indication - Intrinsic Indication and Extrinsic Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 487: Africa 15-Year Perspective for Hydronephrosis Treatment by Indication - Percentage Breakdown of Value Sales for Intrinsic Indication and Extrinsic Indication for the Years 2015, 2025 & 2030
    • TABLE 488: Africa Recent Past, Current & Future Analysis for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 489: Africa Historic Review for Hydronephrosis Treatment by Diagnosis - Laboratory Tests Diagnosis and Imaging Diagnosis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 490: Africa 15-Year Perspective for Hydronephrosis Treatment by Diagnosis - Percentage Breakdown of Value Sales for Laboratory Tests Diagnosis and Imaging Diagnosis for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제